2011, Number 08
<< Back Next >>
Ginecol Obstet Mex 2011; 79 (08)
Breast cancer in Mexican women under 40
Robles-Castillo J, Ruvalcaba-Limón E, Maffuz A, Rodríguez-Cuevas S
Language: Spanish
References: 18
Page: 482-488
PDF size: 328.90 Kb.
ABSTRACT
Background: Breast cancer is the leading cause of death from malignancy in women. The incidence increases with age, but the relationship between age and survival of breast cancer patients is not well defined. It is observed that young women with breast cancer have patterns more aggressive biological
Objective: To determine the frequency, sociodemographic, clinical and histopathological features of breast cancer in women under 40 years attending a specialist breast unit in Mexico City.
Patients and method: Transversal, descriptive and retrospective study of patients under 40 years of age with breast cancer treated between 2005 and 2010.
Results: 1430 cases were diagnosed with breast cancer five years with a mean age of 53.64 ± 11.87 years (range 23 to 93 years), 142 cases were women under 40 years of age (10%). The auto-detection of a breast lump was the most frequent clinical manifestation (50%).
Conclusion: The prevalence of clinical stage III in this age group suggests the difficulty of diagnosis, the high breast density, which is one factor limiting studies of screening with mammography, it diminishes their effectiveness in early detection of breast cancer.
REFERENCES
Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: A review of current American Cancer Society Guidelines and issues in cancer screening. CA Cancer J Clin 2010;60:99-119.
http://www.inegi.org.mx/Sistemas/temasV2/Default.aspx?s=est&c=17484.
Globocan 2008. http://globocan.iarc.fr/.
Casso D, Buist D, Taplin S. Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health and Quality of Life Outcomes 2004;2:1-9.
Aleyamma M, Balakrishnan R, Manoj P. Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis? World Journal of Surgical Oncology 2004;2:1-7.
Gerson R, Serrano A, Flores F, et al. Cáncer de mama en pacientes menores de 35 años. Anales Médicos del Hospital ABC 1997;42(2):50-58.
Abraham J, Gulley JL, Allegra CJ. The Bethesda Handbook of Clinical Oncology. 3ª ed. 2010;151-176.
Rodriguez-Cuevas S, Franceschi D, Labastida S, et al. Breast carcinoma presents a decade earlier in Mexican women that in women in the United States or European Countries. American Cancer Society 2001;91:863-868.
Rosen P, Lesser M, Kinne D, et al. Breast carcinoma in women 35 years of age or younger. Annals of Surgery 1984;199:133-142.
Rizo RP, Sierra CMI, Vázquez PG, et al. Registro hospitalario de cáncer: compendio de cáncer 2000-2004. Instituto Nacional de Cancerología 2007;203-287.
Zabicki K, Colbert J, et al. Breast cancer diagnosis in women lower 40 versus 50 to 60 years: increasing size and stage disparity compared with older women over time. Annals of Surgical Oncology 2006;13:1072-1077.
Xiong Q, Valero V, Kau V, et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis. The MD Anderson Cancer Center Experience. Cancer 2001;92:2523-2528.
Naser E, Dermime S, Ajarim D, et al. Being 40 or younger is an independent risk factor relapse in operable breast cancer patients: The Saudi Arabia experience. BMC Cancer 2007; 7:222.
Gonzalez-Angulo A, Broglio K, Kau S, et al. Women age lower 35 years with primary breast carcinoma. Cancer 2005;103:2466-2472.
Tercera revisión del Consenso Nacional sobre Diagnóstico y Tratamiento del Cáncer Mamario. Ginecol Obstet Mex 2010;78(3):199-212.
Gajdos C, Tartter PL, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancer. Annals of surgery 1999;230(5):692-696.
Osteen R, Cad B, Friedman M, et al. Patterns of care for younger women with breast cancer. J Natl Cancer Inst 1994;16:43-46.
Swason M, Lin Ch. Survival patterns among younger women with breast cancer; the effects of age, race, stage, and treatment. J Natl Cancer Inst 1994;16:69-77.